Science Explorer Back to mapMap
Discussion
Researcher · Fundación Instituto Valenciano de Oncología · Spain

Miguel Á. Climent Durán

Miguel Á. Climent Durán publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment and Prostate Cancer Treatment and Research.

ORCID 0000-0001-7523-0212 OpenAlex
World rank
#1,519,271
of 7,710,434 ranked researchers
Rank in Spain
#31,639
of 204,306
Works
105
Citations
1.2k
Citations per work
11.4
h-index
13
i10-index 19Top 38% in Pulmonary and Respiratory Medicine
Miguel Á. Climent Durán

What does Miguel Á. Climent Durán research?

Miguel Á. Climent Durán's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 75 works · 71.4% of their workMedicine: 75 works · 71.4% of their workPulmonary and Respiratory Medicine: 29 works · 27.3% of their workSurgery: 24 works · 22.7% of their workOncology: 18 works · 17.6% of their workEpidemiology: 4 works · 3.8% of their workEverything else: 18 works · 17.2% of their workLife Sciences: 12 works · 11.4% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 11.4% of their workCancer Research: 6 works · 5.9% of their workMolecular Biology: 6 works · 5.5% of their workTHEIR WORKMiguel Á. ClimentDurán105works
Life Sciences11%Health Sciences71%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7571.4%
  2. Everything else1817.2%
    1. Biochemistry, Genetics and Molecular Biology1211.4%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Surgery23% of their works
  3. 3Oncology18% of their works
  4. 4Cancer Research6% of their works
  5. 5Molecular Biology6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Miguel Á. Climent Durán's research?

The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Genetic Mutations, Neoadjuvant Therapy, Clinical Guidelines, Prostate Cancer, Bladder Cancer and Urothelial Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Immunotherapy793 topics
  2. Molecular Characterization552 topics
  3. Genetic Mutations492 topics
  4. Neoadjuvant Therapy402 topics
  5. Clinical Guidelines342 topics
  6. Prostate Cancer332 topics
  7. Bladder Cancer301 topic
  8. Urothelial Carcinoma301 topic
  9. Metastatic251 topic
  10. Renal Cell Carcinoma251 topic
  11. Androgen Receptor241 topic
  12. Genomic Profiling241 topic
  13. Immune Checkpoint Blockade171 topic
  14. PD-1 and PD-L1171 topic
  15. Esophageal Carcinoma101 topic
  16. Preoperative Chemoradiotherapy101 topic
  17. Radiation Therapy91 topic
  18. Screening91 topic
  19. Chemotherapy-Induced Peripheral Neuropathy81 topic
  20. Kidney Organoids81 topic
  21. Nephrogenesis81 topic
  22. Taxanes81 topic

Where does Miguel Á. Climent Durán work?

Miguel Á. Climent Durán's main affiliation in the publication record is Fundación Instituto Valenciano de Oncología, Spain.

How many publications and citations does Miguel Á. Climent Durán have?

OpenAlex counts 105 works and 1,200 citations for Miguel Á. Climent Durán, an h-index of 13, ranking #1,519,271 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Miguel Á. Climent Durán. Posts are plain text and can be reported.